HopeStage
Back to all studies
CompletedNCT00879996

Buprenorphine or methadone for opioid use and chronic pain

About this titleRead the official source — NCT00879996
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Buffalo and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2009
Recruitment status
Completed
Enrollment listed in the registry
54
Sponsor
State University of New York at Buffalo
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00879996
Official title
Show the full official title

A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Buffalo

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is State University of New York at Buffalo, a university.

Did this study involve medication?

Yes. The study involved medication, including Methadone and Buprenorphine/naloxone.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies